Featured Publications
Public Health Impacts of Vaccines for COVID-19 and Beyond: Opportunities to Overcome Technical and Regulatory Barriers for Randomized Trials.
Kennedy-Shaffer L. Public Health Impacts of Vaccines for COVID-19 and Beyond: Opportunities to Overcome Technical and Regulatory Barriers for Randomized Trials. American Journal Of Public Health 2023, 113: 778-785. PMID: 37104734, PMCID: PMC10262256, DOI: 10.2105/ajph.2023.307302.Peer-Reviewed Original ResearchConceptsPublic health impactCOVID-19 pandemicPopulation healthEvidence baseCOVID-19Health impactsInfectious disease outbreaksCommunity levelRandomized trialsIndividual levelRegulatory barriersPivotal trialsClinical benefitTrialsClinical trialsVaccine trialsPrevent infectionStrategic deploymentVaccineHealth
2021
How to detect and reduce potential sources of biases in studies of SARS-CoV-2 and COVID-19
Accorsi E, Qiu X, Rumpler E, Kennedy-Shaffer L, Kahn R, Joshi K, Goldstein E, Stensrud M, Niehus R, Cevik M, Lipsitch M. How to detect and reduce potential sources of biases in studies of SARS-CoV-2 and COVID-19. European Journal Of Epidemiology 2021, 36: 179-196. PMID: 33634345, PMCID: PMC7906244, DOI: 10.1007/s10654-021-00727-7.Peer-Reviewed Original ResearchConceptsRisk Factors StudyPublic health scientistsPotential sources of biasBody of literatureSources of biasStudy designFactor studiesHealth scientistsCategories of studiesObservational studyCOVID-19Selection biasPotential biasSecondary attack rateRisk of infectionGeographical areasAttack rateRiskSusceptibility to infectionStudy of COVID-19Cross-sectional seroprevalenceConfoundingCoronavirus diseaseIntervention